From owner-diagnostics@net.bio.net Thu Sep 02 13:14:00 1999 Path: biosci!biosci!not-for-mail From: Larry Winger [mailto:Larry.Winger@ncl.ac.uk] Newsgroups: bionet.diagnostics Subject: ?Alchemy gold conjugation outfit in UK Date: 2 Sep 1999 07:14:19 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 14 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7qm0nr$5bp@net.bio.net> NNTP-Posting-Host: net.bio.net I'm looking for contact information for a company I've heard referred to as Alchemy, who do gold conjugation to immunoglobulin. Any contact advice would be much appreciated. cheers Larry Winger Larry A. Winger, PhD, Senior Research Associate Clinical Biochemistry, Medical School, Univ. Newcastle upon Tyne Newcastle upon Tyne, United Kingdom, NE2 4HH 44(0)191 222 6000 x8549 http://georgia.ncl.ac.uk/profb.html From owner-diagnostics@net.bio.net Fri Sep 03 09:11:00 1999 Path: biosci!biosci!not-for-mail From: BIOSCI Administrator [mailto:biohelp@net.bio.net] Newsgroups: bionet.diagnostics Subject: BIOSCI/bionet miniFAQ & Fundraiser Date: 3 Sep 1999 03:11:01 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 241 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7qo6rl$50e@net.bio.net> NNTP-Posting-Host: net.bio.net (LAST REVISION: 14-AUG-99) This BIOSCI "miniFAQ" is designed to answer the questions that come up the *most frequently*. The main BIOSCI FAQ (Frequently Asked Questions) is accessible on the World Wide Web at URL http://www.bio.net/. If you can not find an answer to your question in this or other documentation, the BIOSCI technical support staff answers e-mail queries sent to biosci-help@net.bio.net We can only answer questions about the use of the newsgroups and mailing lists. We unfortunately do not have the staff to do Internet information searches or answer scientific questions. Please post those to the appropriate BIOSCI/bionet newsgroups. Contents: -------- 0) BIOSCI NEEDS YOUR SUPPORT!! 1) Using the WWW to access the BIOSCI/bionet newsgroups. 2) What to do about "spams," i.e., junk mail, ads, etc. 3) Examples of subscribing and unsubscribing to the mailing lists. 4) The BIOSCI user address and research interest directory. 0) BIOSCI NEEDS YOUR SUPPORT!! ------------------------------ BIOSCI's government funding has been expended, and we are now operating solely from advertising revenue that we have raised from our Web site at http://www.bio.net/. We need just a few minutes of your time to help us serve you. You can do two important things which will take very little time for you individually and will immensely help us continue to help you. First, please use our WWW system at http://www.bio.net/ to access the archives. You can post or reply to messages via your Web browser as described in item #1 below. Your usage helps attract sponsors. If you contact any of our sponsors, please be sure to thank them for supporting BIOSCI. It is critical for them to get this feedback if they are to continue their sponsorship for the long term. Second, if you work for a company or organization that provides products or services of interest to the biology community, please pass this message on to your marketing or marketing communications department or other appropriate group. Please ask them to help support BIOSCI by sponsoring our Web site and explain the uses and benefits of the system to the biology community. If they are interested, they can then contact us for further information at our tech support address, biosci-help@net.bio.net. 1) Using the WWW to access the BIOSCI/bionet newsgroups. -------------------------------------------------------- All BIOSCI/bionet full newsgroups are accessible through the World Wide Web (WWW) at URL http://www.bio.net. One can read and reply publicly or privately to both recent postings and archived messages through one's Web browser if it is configured properly to send e-mail. Each newsgroup is equipped with its own WAIS index. The main BIOSCI home page also has access to the BIO-JOURNALS Table of Contents database WAIS index and the BIOSCI user address database described in another item further below. 2) What to do about "spams," i.e., junk mail, ads, etc. ------------------------------------------------------- BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups), mailing lists, and a hypermail archive at URL http://www.bio.net/. The same postings are distributed on all media (except for a small number of mailing-list-only groups at net.bio.net). Unfortunately it is becoming a despicable practice on the Internet (by a few people out to make a fast buck) to do automated mass postings to thousands of newsgroups and mailing lists. These attempts to grab free advertising are refered to as "spams" in the usual, somewhat boneheaded, net terminology. USENET is more susceptible to this practice, and many spams originate on the USENET groups and then are passed on to the mailing lists. However, spammers also get lists of mailing addresses and hit these too, so neither medium is immune. What should you do personally if you get junk mail? --------------------------------------------------- Just delete it and move on without reading it further. Filing a protest is becoming increasingly useless because spammers are often disguising the addresses where the messages are sent from. Unless you really understand Internet mail systems, your attempt at protest by sending replies to the message will often end up being sent to the address of an innocent person that the spammer is victimizing. What can BIOSCI/bionet do to protect its newsgroups? ---------------------------------------------------- The only solution currently available is to moderate the newsgroup. If this newsgroup is already moderated, then you are in good shape. Moderation protects the USENET distribution from about 95% of the spams that are being sent to date and protects the mailing lists completely. Moderation means, however, that someone has to take the time to review each message before it goes out. We have set up software here that simply allows the moderator to forward to an address at net.bio.net messages that (s)he wishes to have distributed. This takes no more time than that needed to read the message and pass it on, say about 1 min. per message. Most newsgroups currently have a discussion leader who is responsible for their newsgroup. The discussions leaders and their e-mail addresses are listed in the BIOSCI Information Sheet which is available on the Web at http://www.bio.net/. If a newsgroup is being hit with too many junk postings, please contact the discussion leader for that group and see if there is interest in moderating the group. Please do not assume that by simply posting a complaint to the newsgroup itself, anyone on the BIOSCI staff will act on your complaint. With close to 100 newsgroups to run, the BIOSCI staff has to rely on the discussion leaders of each newsgroup to report problems directly to us at biosci-help@net.bio.net. We will moderate any of our newsgroups if the discussion leader tells us that the readership of the group wishes to do so and if a moderator is willing to do the work. For most BIOSCI/bionet groups, this entails only a few minutes of work each day. Moderating a newsgroup will resolve probably 95% of the junk postings on the USENET distribution. Unfortunately there are easy ways for determined spammers to override the moderation mechanism on USENET, but we can protect our e-mail subscribers from unwanted postings if the newsgroup is moderated. You can also access our newsgroups over the WWW at URL http://www.bio.net. While this Web interface will not stop spammers from trying to post to the groups, this will give you yet another way, besides using USENET news, to keep the junk out of your personal mail files. For those of you with local USENET news systems, the Web interface will also give you faster access to new newsgroups and recent postings. 3) Examples of subscribing and unsubscribing to the mailing lists. ------------------------------------------------------------------ PLEASE NOTE: The BIOSCI management does NOT act on subscription/unsubscription requests that are posted improperly to the newsgroups and mailing lists. People who do this only bother everyone on the lists to no avail. Please be sure to follow the proper procedures below. Gory details are in the BIOSCI Information sheets on the Web at http://www.bio.net. Below we give an example utilizing the METHODS-AND-REAGENTS list at both of our two BIOSCI sites: Users in the Americas and Pacific Rim countries who use the BIOSCI ------------------------------------------------------------------ node at computer net.bio.net: ---------------------------- A) Determine the "listname" which is the <=8 character mail address ^^^^^^^^^^^^^ for the group. These can be found in the BIOSCI Info. Sheet. For the METHODS-AND-REAGENTS group the mailing address is methods@net.bio.net. The listname is the portion of the address to the left of the @ sign, i.e., "methods". The listname is used with the "subscribe" and "unsubscribe" commands illustrated below. B) Mail all commands in the body of a mail message addressed to biosci-server@net.bio.net. Do NOT send commands to the newsgroup posting addresses! Leave the Subject: line blank, any text on it will be ignored. C) In the body of your message put one or more of the following commands with an "end" command on the last line, e.g., subscribe methods unsubscribe methods end Do NOT put your e-mail address or other text on these lines. The server only allows you to cancel your subscription if the address on your mail header matches the address on our mailing list. Please ask for help at biosci-help@net.bio.net if your address has changed, e.g., if you know you are on the list but the server tells you that you are not a member. Users in Europe, Africa, and Central Asia who use the BIOSCI node at -------------------------------------------------------------------- the UK-HGMP-Resource Centre (known as hgmp.mrc.ac.uk): ----------------------------------------------------- A) Determine the "listname" which is the <=8 character mail address ^^^^^^^^^^^^^ for the group. These can be found in the BIOSCI Info. Sheet. For the METHODS-AND-REAGENTS group the mailing address is methods@hgmp.mrc.ac.uk. The listname is the portion of the address to the left of the @ sign, i.e., "methods". The listname is used with the "subscribe" and "unsubscribe" commands illustrated below. B) Mail all commands in the body of a mail message addressed to majordomo@hgmp.mrc.ac.uk. Do NOT send commands to the newsgroup posting addresses! Leave the Subject: line blank, any text on it will be ignored. C) In the body of your message put one or more of the following commands with an "end" command on the last line, e.g., subscribe methods unsubscribe methods end Please ask for help at biosci@hgmp.mrc.ac.uk if your address has changed, e.g., if you know you are on the list but the server tells you that you are not a member. 4) The BIOSCI user address and research interest directory. ----------------------------------------------------------- Please take this opportunity to add your name, address, and research interest information to the BIOSCI User Address Database if you have not already done so. You can fill out the address form directly through our Web page at URL http://www.bio.net/adrform.html. The address database is reindexed nightly for WWW access (the URL is http://www.bio.net/). If you are not directly on the Internet but can reach it by e-mail, please use our waismail server to access the user directory. waismail use is described above. You can also request a user address form by e-mail from biosci-help@net.bio.net. Please check your database entry from time-to-time to see if your address information is still up-to-date. Because of our limited personnel resources, we ask that you resubmit a *complete* form to revise your entry; we only replace complete entries and do not have resources to edit old forms. From owner-diagnostics@net.bio.net Thu Sep 09 11:02:00 1999 Path: biosci!biosci!not-for-mail From: stewartl@best.com [mailto:stewartl@best.com] Newsgroups: bionet.diagnostics Subject: PCR-Based Detection Kits Date: 9 Sep 1999 05:02:11 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 25 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7r87k3$602@net.bio.net> NNTP-Posting-Host: net.bio.net This month in Alkami PCR Reviews, Dr. Michael Zwick talks about the advantages and disadvantages of PCR-Based Detection Kits at http://www.alkami.com/reviews/mszver02.htm Last month's column discussed the lack of PCR-based diagnostic kits in clinical settings in "Why Aren't PCR-Based Diagnostics Main Stream?" at http://www.alkami.com/reviews/mszver01.htm. Reasons ranged from a lack of acceptance by the clinical lab to the many sub-licensing contracts required for a company to sell a PCR-based diagnostic kit. The Alkami Biosystems site, http://www.alkami.com, is a comprehensive resource for the polymerase chain reaction. We have online references that include primer design tips and tools, reagent concentrations, polymerase characteristics, PCR methods, and temperature calculations.In addition, you will find regular reviews of PCR issues, employment resources for the biologist, as well as special FREE lab supply offers at http://www.alkami.com/products/idxprods.htm Thanks for your interest. --- ALKAMI BIOSYSTEMS, Inc. Simplified Solutions for Complex Questions (tm) info@alkami.com http://www.alkami.com P.O. Box 11216 Berkeley CA 94712 USA From owner-diagnostics@net.bio.net Fri Sep 10 07:02:00 1999 Path: biosci!biosci!not-for-mail From: Yves Hurtubise [mailto:yves_hurtubise@tr.cgocable.ca] Newsgroups: bionet.diagnostics Subject: Sporulation of bacillus Date: 10 Sep 1999 01:02:18 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 8 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7radua$ckv@net.bio.net> NNTP-Posting-Host: net.bio.net I try to sporulate bacillus licheniformis and I have many problem. Any solutions?? Thank you! Yves Hurtubise From owner-diagnostics@net.bio.net Mon Sep 13 08:01:00 1999 Path: biosci!biosci!not-for-mail From: Stuart Harbron [mailto:s.harbron@experts.co.uk] Newsgroups: bionet.diagnostics Subject: Diagnostic Insight launches Company Profiles Date: 13 Sep 1999 02:00:43 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 32 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7riefr$4ap@net.bio.net> NNTP-Posting-Host: net.bio.net Diagnostic Insight launches Company Profiles - September 11, 1999 Each month Diagnostic Insight provides key Company Intelligence - a league table of patent activity gives you a feel for which companies are leading the field in molecular diagnostics. Summary tables give an easy-to-see breakdown of patent activity into imprtant categories: Infection, Disease, Analyte and Method. These are subdivided by diagnostic target. Now we are providing Company Profiles - these give a thumb nail sketch of patenting activity and trends. Find out which companies were most active in patents during 1998 and take a look at their profiles at: http://www.etc.uk.com/DI/company.htm 1999 data will soon be available to subscribers only. Stuart Harbron, PhD Principal Consultant The Enzyme Technology Consultancy Tel: (+44) 1442 385740 Fax: (+44) 8700 888270 mailto:s.harbron@experts.co.uk http://www.experts.co.uk From owner-diagnostics@net.bio.net Tue Sep 14 07:44:00 1999 Path: biosci!biosci!not-for-mail From: Scott Minns [mailto:smeg2cletus@my-deja.com] Newsgroups: bionet.diagnostics Subject: Tetanus Toxoid Date: 14 Sep 1999 01:44:19 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 11 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7rl1t3$mbq@net.bio.net> NNTP-Posting-Host: net.bio.net I am looking for an alternative supplier of tetanus toxoid to be used as ELISA plate coating antigen. We havehad problems with our current supplier not being able to supply the toxoid. Thanks in advance for your time and effort. Sent via Deja.com http://www.deja.com/ Share what you know. Learn what you don't. From owner-diagnostics@net.bio.net Tue Sep 21 07:27:00 1999 Path: biosci!biosci!not-for-mail From: Andrew M Smith [mailto:andrew@selectscience.net] Newsgroups: bionet.diagnostics Subject: Rate lab equipment online (G-L) Date: 21 Sep 1999 01:27:17 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 59 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7s7fh5$ppd@net.bio.net> NNTP-Posting-Host: net.bio.net Have you recently bought a new piece of equipment for your laboratory? If so, come to www.selectscience.net and tell us what you think of it. We are an independent group dedicated to helping scientists find the most appropriate equipment for their applications. If you have bought any of the products below, simply click on the link, tell us who you are (so we can make sure you're not simply a salesman trying to promote your product), and give us your opinion on your piece of equipment. GC chemiluminescence detector www.selectscience.net/default.asp?CatID=247 GC system (analytical scale) www.selectscience.net/default.asp?CatID=256 GC-MS system www.selectscience.net/default.asp?CatID=265 Gel documentation equipment www.selectscience.net/default.asp?CatID=1676 High speed, benchtop refrigerated centrifuge www.selectscience.net/default.asp?CatID=186 HPLC system (analytical scale) www.selectscience.net/default.asp?CatID=344 Incubator www.selectscience.net/default.asp?CatID=684 Kjledahl apparatus www.selectscience.net/default.asp?CatID=922 LC-MS system www.selectscience.net/default.asp?CatID=352 Liquid dispensers www.selectscience.net/default.asp?CatID=812 Luminescence microplate reader www.selectscience.net/default.asp?CatID=1874 If you can't find your new item in this list, simply come to www.selectscience.net and use our powerful search engine to find it. We are waiting for your visit. Andrew Smith Editor, www.selectscience.net From owner-diagnostics@net.bio.net Tue Sep 21 08:10:00 1999 Path: biosci!biosci!not-for-mail From: Andrew M Smith [mailto:andrew@selectscience.net] Newsgroups: bionet.diagnostics Subject: Last week's news headlines Date: 21 Sep 1999 02:09:58 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 60 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7s7i16$1tg@net.bio.net> NNTP-Posting-Host: net.bio.net In the last seven days, www.selectscience.net has reported on 24 news stories the day they happened, so if you need to keep up to speed on the latest business developments in chemistry and life science, make the news ticker on www.selectscience.net part of your daily routine. Andrew Smith (andrew@selectscience.net) Editor, www.selectscience.net The last week's headlines were: deCODE genetics of Iceland Maps a Gene Linked to pre-eclampsia Peptide Therapeutics Group plc: Interim Results for the Six Months Ended 30 June 1999 & Proposed Spin-Out of Drug Discovery Activities Affymetrix, Inc. Announces Exercise of Share Purchase Option Affymetrix, Inc. Raises $125 Million in Convertible Subordinated Debt Placement Bacterial Virus And Human Adenovirus Found to be Similar Biotech entrepreneurs need assistance, say workshop participants Oxford GlycoSciences and Cellular Genomics, Inc., Establish Joint Proteome Program PE Corporation to Enter Alliance With New Venture Led By Dr. Noubar Afeyan Celera Genomics Completes Sequencing Phase of Drosophila Genome Project Aurora Biosciences Announces Director Resignation Aurora Biosciences Announces Drug Discovery Program Funded By The Cystic Fibrosis Foundation Affymetrix to Acquire Genetic Mictosystems DuPont and MIT Form Biotechnology Alliance Judgement in Favor of Affymetrix in Patent Interferences Oxford GlycoSciences Reports 1999 Interim Results Abbott Laboratories Declares 303rd Consecutive Quarterly Dividend Hughes Institute Scientists Announce a New Paradigm for the Treatment Of Asthma and Allergy New Chemical Entities, Inc. and Thetagen, Inc. Merge Myriad Genetics Forms Strategic Alliance With Galileo Genomics Cellomics Announces Major Expansion Into Europe From owner-diagnostics@net.bio.net Wed Sep 22 07:18:00 1999 Path: biosci!biosci!not-for-mail From: 915613@candseek.com [mailto:915613@candseek.com] Newsgroups: bionet.diagnostics Subject: JOBOP Toxicology Scientist Date: 22 Sep 1999 01:18:12 -0700 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 74 Sender: daemon@net.bio.net Approved: odonnell@sasa.gov.uk Distribution: world Message-ID: <7sa3c4$cc6@net.bio.net> NNTP-Posting-Host: net.bio.net Since your email address was listed on a related web site page or database, I thought you might help. I am seeking an individual within the following conditions: A Ph.D. toxicologist to work in a lab that is responsible for the direction of the screening and development efforts on the safety evaluation of novel biopharmaceutical products for the treatment of CNS disorders and drug delivery polymer products for the treatment of cancer. The qualified candidate should have excellent interpersonal skills and the ability to work closely on project team efforts for bringing novel therapies forward to proof of principle in clinical evaluation. The ability to interpret results and summarize study conclusions clearly and concisely is essential. Our client is a leading biotech firm with research facilities in Maryland and can provide excellent benefits (health insurance, dental, and vision plan, paid vacation and more). A high impact, high profile position with excellent opportunity for advancement. Geographic Location of Position: US-MD If you know anyone that might be interested, please forward this to them or contact: Bob Griese Diedre Moire Corporation Fax: 609-584-9575 voice 609-584-8733 ext. 235 Email: 915613@candseek.com To permanently discontinue receiving employment opportunity notices from any and all help wanted advertisers using the Candidate Seeker system, click your "Reply" button and type the word "re- move" without spaces between the letters into the SUBJECT field then click the "Send" button. Your email address will be permanently filtered from ALL future job opportunity notifications sent via the Candidate Seeker system. To temporarily filter employment opportunity notices sent via the Candidate Seeker system, type the acronym "JOBOP" into your subject filter. All employment opportunity notices sent via the Candidate Seeker system contain the acronym "JOBOP" in the subject so they may be easily filtered or blocked if so desired. Other email addresses may be permanently deleted from future contact by emailing a single blank message from the desired address to nomail@candseek.com. Enter additional addresses into the body of the message and they will also be added to the "nomail" list Please feel free to contact the candidateseeker.com feedback line at 609-584-5499. Do not use this number for job related questions. All job related questions should be directed to the employer by replying to contact addresses or phone numbers indicated at the end of the job description message. Mailed By: candseek.com 510 Horizon Center Robbinsville, NJ 08691